RecruitingPhase 1NCT07290036
A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults
Studying NON RARE IN EUROPE: Psoriatic arthritis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- UCB Biopharma SRL
- Principal Investigator
- UCB Cares001 844 599 22733 (UCB)
- Intervention
- Bimekizumab regimen 1 iv(drug)
- Enrollment
- 392 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2025 – 2028
Study locations (20)
- Pa0019 114, Peoria, Arizona, United States
- Pa0019 127, Apple Valley, California, United States
- Pa0019 111, Covina, California, United States
- Pa0019 117, Riverside, California, United States
- Pa0019 125, San Leandro, California, United States
- Pa0019 126, Temecula, California, United States
- Pa0019 120, Whittier, California, United States
- Pa0019 128, Whittier, California, United States
- Pa0019 123, Fort Collins, Colorado, United States
- Pa0019 113, South Miami, Florida, United States
- Pa0019 134, Lansing, Michigan, United States
- Pa0019 140, West Long Branch, New Jersey, United States
- Pa0019 131, Albuquerque, New Mexico, United States
- Pa0019 115, Duncansville, Pennsylvania, United States
- Pa0019 116, Jackson, Tennessee, United States
- +5 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07290036 on ClinicalTrials.govOther trials for NON RARE IN EUROPE: Psoriatic arthritis
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT06382051Modifying PEST for Psoriatic Arthritis ScreeningNovartis Pharmaceuticals
- RECRUITINGPHASE2NCT06176508Efficacy and Safety of HS-10374 Compared to Placebo in Adults With Active Psoriatic ArthritisHansoh BioMedical R&D Company
- ENROLLING BY INVITATIONNANCT06176586Mat Pilates Exercise Program in Patients With Axial Psoriatic ArthritisIzmir Katip Celebi University
- RECRUITINGNCT06437392Evaluation of Sarcopenia and Related Factors in Patients Diagnosed With Psoriatic ArthritisAnkara City Hospital Bilkent
- RECRUITINGNCT07277491Assessment of Nutritional Status in Rheumatic Diseases and Association to Disease ActivityCairo University
- ACTIVE NOT RECRUITINGPHASE3NCT04908189A Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are Naïve to Biologic Disease Modifying Anti-rheumatic Drugs or Had Previously Received TNFα Inhibitor TreatmentBristol-Myers Squibb
- RECRUITINGNCT03768271APACHE Cohort (A Psoriatic Arthritis CoHort)Assistance Publique - Hôpitaux de Paris
- ACTIVE NOT RECRUITINGPHASE3NCT03671148A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis Including Those Who Have a History of Inadequate Response or Intolerance to Biologic Therapy(Ies)AbbVie
See all trials for NON RARE IN EUROPE: Psoriatic arthritis →